Pramipeksol İlişkili Uygunsuz Antidiüretik Hormon Salınımı Sendromu
Öz
Anahtar Kelimeler
Kaynakça
- van Laar T, Lammers GJ, Roos RA, Gerritsen JJ, Meinders AE. Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion. Mov Disord 1998;13(1):176-8.
- Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014;170(2):1-47.
- Martin J, Burnier M, Lu H. Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Rev Med Suisse 2018;14(628):2116-20.
- Navarro HA, Sánz-Aiz A, Izquierdo L, Jiménez FJJ. Syndrome of inappropriate antidiuretic hormone secretion possibly associated with amantadine therapy in Parkinson disease. Clin Neuropharmacol 2009;32(3):167-8.
- Tomita M, Otsuka Y, Iida R, Kobayashi S, Kuriyama S, Hosoya T. Syndrome of inappropriate ADH secretion (SIADH) induced by pramipexole in a patient with Parkinson's disease. Nihon Jinzo Gakkai Shi 2005;47(5):531-5.
- Arai M, Iwabuchi M. Pramipexole as a possible cause of the syndrome of inappropriate antidiuresis. BMJ Case Reports 2009 (2009): bcr0120091484.
- Choi Y, Park JJ, Ryoo NY, Kim SH, Song C, Han IT, et al. Syndrome of inappropriate antidiuretic hormone secretion associated with pramipexole in a patient with Parkinson’s disease. J Mov Disord 2011;4(1):46.
- Azdad K, Piet R, Poulain DA, Oliet SH. Dopamine D4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 2003;90(2):559-65.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yazarlar
Fettah Eren
*
0000-0001-6834-0827
Türkiye
Aysegul Demir
0000-0002-5444-9837
Türkiye
Güllü Eren
0000-0003-4033-7946
Türkiye
Yayımlanma Tarihi
20 Aralık 2020
Gönderilme Tarihi
10 Haziran 2020
Kabul Tarihi
10 Eylül 2020
Yayımlandığı Sayı
Yıl 1970 Cilt: 8 Sayı: 3